tm logo
3D PREDICT GLIOMA
Dead/Abandoned
ABANDONED - AFTER EX PARTE APPEAL

after ex parte appeal

on 08 Feb 2024

Last Applicant/ Owned by

900-B W Faris Road

Greenville

SC

29605

Serial Number

90818258 filed on 08th Jul 2021

Registration Number

N/A

Correspondent Address

KATHRYNN M. LYDDANE

Kathrynn M. Lyddane

P.O. BOX 1449

GREENVILLE SC 29602-1449

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

3D PREDICT GLIOMA

Medical research services related to predictive tests for patient benefit from anti-cancer drugs or combination of drugs; Pharmaceutical research services, namely, preclinical assessment of pharmaceutical drugs; Scientific and technological services, namely, research in the field of anti-cancer therapies using ex vivo assays; Medical testing services, namely, performing nonclinical assays and test Read More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Medical clinical testing services for diagnostic or treatment purposes, namely, conducting predictive patient-specific clinical assays, modeling and assessing response of live cancer cells to investigational and approved cancer therapies; Medical services in the nature of personalized medicine services, namely, conducting predictive patient-specific clinical assays, modeling and assessing response of live cancer cells to investigational and approved cancer therapies

Class [042]
Computer & Software Services & Scientific Services


Medical research services related to predictive tests for patient benefit from anti-cancer drugs or combination of drugs; Pharmaceutical research services, namely, preclinical assessment of pharmaceutical drugs; Scientific and technological services, namely, research in the field of anti-cancer therapies using ex vivo assays; Medical testing services, namely, performing nonclinical assays and testing for medical research purposes in the field of anti-cancer therapies, not for diagnostic or treatment purposes; Providing medical and scientific research information in the field of clinical trials, assays, and assay development, and cancer; Laboratory research in the field of oncology

Class [010]
Medical Instrument Products


Medical apparatus, devices, and instruments for the analysis of tumor response to anti-cancer therapies; Kit comprising medical apparatus, devices, and instruments for performing clinical assays of anti-cancer therapies

Class [009]
Computer & Software Products & Electrical & Scientific Products


Scientific instruments and apparatus for ex vivo three-dimensional cell culture, namely, bioreactor for cell culturing, for laboratory use; scientific instruments and apparatus for ex vivo microtumor modeling

Class [005]
Pharmaceutical Products


Assay kits comprising clinical medical reagents for culturing cells for clinical medical use

Class [001]
Chemical Products


Assays for clinical laboratory or research purposes, namely, for testing anti-cancer therapies, other than for medical or veterinary use; Assays for use in anti-cancer therapy research; Assays for testing cellular response to anti-cancer therapies, other than for medical or veterinary use; Assay kits comprising cell culture reagents and assays for culturing cells for clinical laboratory or research use

Mark Details


Serial Number

No 90818258

Mark Type

No Service Mark

Attorney Docket Number

No KIYA-13-TM

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
08th Feb 2024EXPARTE APPEAL TERMINATED
08th Feb 2024ABANDONMENT - AFTER EX PARTE APPEAL
08th Feb 2024ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
29th Dec 2023EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF
18th Oct 2023ACTION CONTINUING FINAL - COMPLETED
18th Oct 2023ACTION DENYING REQ FOR RECON E-MAILED
18th Oct 2023NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
18th Aug 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
18th Aug 2023TEAS/EMAIL CORRESPONDENCE ENTERED
27th Apr 2023EXPARTE APPEAL RECEIVED AT TTAB